Bellevue Group’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$123K Sell
536
-23,794
-98% -$5.33M ﹤0.01% 136
2025
Q4
$5.19M Sell
24,330
-573
-2% -$118K 0.1% 74
2025
Q3
$4.95M Sell
24,903
-3,752
-13% -$700K 0.1% 75
2025
Q2
$4.95M Buy
28,655
+26,755
+1,408% +$4.36M 0.11% 82
2025
Q1
$296K Sell
1,900
-600
-24% -$85.7K 0.01% 128
2024
Q4
$344K Buy
+2,500
New +$329K 0.01% 130
2021
Q2
Sell
-15,500
Closed -$2M 215
2021
Q1
$2M Hold
15,500
0.02% 143
2020
Q4
$2.58M Hold
15,500
0.03% 140
2020
Q3
$2.39M Buy
15,500
+2,200
+17% +$316K 0.03% 141
2020
Q2
$1.97M Buy
13,300
+1,400
+12% +$192K 0.03% 135
2020
Q1
$1.34M Buy
+11,900
New +$1.55M 0.03% 136
2019
Q4
Sell
-13,600
Closed -$1.31M 217
2019
Q3
$1.31M Sell
13,600
-4,600
-25% -$513K 0.02% 133
2019
Q2
$2.1M Hold
18,200
0.04% 129
2019
Q1
$2.14M Buy
+18,200
New +$1.59M 0.12% 104

Other funds holding ASND